Sullivan Papain is representing patients who suffered severe vision loss after using Ozempic and Wegovy, as highlighted in recent media coverage by Fox and the New York Post. These reports underscore the serious underreported risk of non-arteritic anterior ischemic optic neuropathy (NAION), a condition causing permanent blindness, allegedly linked to these popular weight loss drugs. Our firm is committed to holding Novo Nordisk accountable and raising awareness to protect patients.
In the New York Post, attorney Craig Silverman discussed our representation of two clients: Cilette Mitchell, a 64-year-old California grandmother of 11, and a New Jersey resident. Both developed NAION after using Ozempic and Wegovy in 2023, resulting in life-altering vision loss. Mitchell shared, “I can no longer fully see my grandchildren’s faces during life’s precious moments.” The New Jersey client, now reliant on his spouse, can no longer drive or read. Their lawsuits, filed in New Jersey state court, allege Novo Nordisk failed to warn about NAION risks, despite evidence suggesting an increased likelihood among users.
Fox recently reported on a small study linking GLP-1 drugs like Ozempic and Wegovy to vision problems, including NAION, reinforcing concerns raised in a 2024 Journal of the American Medical Association study. These findings highlight the urgent need for transparency, as NAION’s devastating impact—permanent vision loss—remains absent from the drugs’ warning labels. Patients have a right to know the risks presented by using Ozempic and Wegovy, which generated over $25 billion in global sales last year.
Sullivan Papain’s experienced legal team is at the forefront of these lawsuits, seeking justice and compensation for those harmed. “We’re fighting to ensure pharmaceutical companies prioritize patient safety,” said Silverman. By shedding light on our clients’ stories, we aim to protect others from similar harm and push for clearer warnings.
If you or a loved one experienced vision loss or other serious side effects after using Ozempic or Wegovy, contact Sullivan Papain for a confidential consultation. Our attorneys are here to listen, guide you through your legal options, and advocate for your rights. Raising awareness about NAION can help safeguard our community.